
GC75237
Lck-IN-1
Also known as N-propyl-3-pyridin-4-ylimidazo[1,2-b]pyridazin-6-amine
Lck-IN-1 is a potent lymphocyte protein tyrosine kinase (Lck) inhibitor extracted from patent WO2007013673A1, example 48
ChemicalCAS923596-52-5MW253.3FormulaC14H15N5
- CAS number
- 923596-52-5
- Molecular weight
- 253.3
- Formula
- C14H15N5
- InChIKey
- XTMROGQLIVGYKF-UHFFFAOYSA-N
- Catalogue number
- GC75237
- Brand
- GLPBIO
Computed properties PubChem CID 68488430 · XLogP 2.1 · TPSA 55.1 Ų · H-bond donors 1
- XLogP
- 2.1
- TPSA
- 55.1 Ų
- H-bond donors
- 1
- H-bond acceptors
- 4
- Rotatable bonds
- 4
- Heavy atoms
- 19
SMILES CCCNC1=NN2C(=NC=C2C3=CC=NC=C3)C=C1
Computed descriptors from PubChem (CID 68488430), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il